Back to results
US 2021/0171554 A1Published application
Benzothiophene estrogen receptor modulators to treat medical disorders
AssigneeG1 Therapeutics, Inc.
InventorJay Copeland Strum
Life of this patent
Estimating the term…
Abstract
This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt, N-oxide, isotopic derivative, or prodrug thereof or a pharmaceutically acceptable composition thereof to treat an estrogen-related medical disorder. The invention also includes a combination thereof with another active agent such as a CDK inhibitor, including a CDK4/6 inhibitor, to treat a disorder mediated by the estrogen receptor, as described in more detail herein.
Claims20
A compound selected from:
- or a pharmaceutically acceptable salt thereof;
- wherein
- A is:
- m is 1, 2, or 3;
- n is 0, 1, 2, 3, or 4;
- o is 0, 1, 2, 3, 4, or 5;
- each Q is independently selected from the group consisting of —CHR5— and —CH2—;
- Z1 is —O—, —C(R3)2—, or —S—;
- Z2 is bond, —O—, —C(R3)2—, or —S—;
- Z3 is —O— or —S—;
- each R1 is independently selected from the group consisting of C1-C5alkyl, halogen, and C1-C3haloalkyl;
- R2 is selected from the group consisting of hydroxyl, alkoxy, —NH—(CH2)n1—NR6R7, —NR6R7, 4-10 membered heterocycle, and 6-12 membered bicyclic heterocycle;
- wherein each heterocycle is optionally substituted with one, two, or three groups independently selected from R4;
- n1 is 2, 3, 4, 5, or 6;
- each R3 is independently selected from the group consisting of hydrogen, halogen, C1-C3alkyl, and C1-C3haloalkyl;
- each R4 and R5 are independently selected from the group consisting of hydrogen, halogen, C1-C5alkyl, C1-C5haloalkyl, —COOH, —COOC1-C5alkyl, —CONH2, —CON(H)alkyl, and —CON(alkyl)2;
- or two R4 substituents on the same carbon atom are optionally combined together with the carbon to which they are attached to form a
- group, wherein n3 is 1, 2, 3, 4, or 5;
- R6 and R7 are independently selected at each instance from the group consisting of hydrogen, C1-C12alkyl, and C2-C12haloalkyl;
- R8 is selected from the group consisting of —C(O)R9, —OC(O)R9, —OP(O)(OR10)2, and —P(O)(OR10)2;
- R9 is selected from the group consisting of hydrogen, C1-C5alkyl, —OR6, and —NR6R7;
- each R10 is independently selected from the group consisting of hydrogen, C1-C5alkyl, and —C(O)C1-C5alkyl;
- R11 is a 4-10 membered monocyclic heterocycle or a 6-12 membered bicyclic heterocycle;
- wherein each heterocycle is optionally substituted with one, two, or three substituents independently selected from R4, and wherein the heterocycle is attached through a carbon atom;
- R12 is a 5, 6, or 7-membered monocyclic or 6-12 membered bicyclic heterocycle;
- wherein each heterocycle is optionally substituted with one, two, or three substituents independently selected from R4, and wherein the heterocycle is attached through a carbon atom;
- R13 is selected from the group consisting of hydroxyl, —C(O)R9, —OC(O)R9, —OP(O)(OR10)2, and —P(O)(OR10)2;
- and R14, R15, and R16 are independently selected from the group consisting of hydrogen, C1-C5alkyl, halogen, and C1-C3haloalkyl;
- wherein at least one of R14, R15, and R16 is C1-C5alkyl, halogen, or C1-C3haloalkyl.
26 more elements
Dependencies are inferred from the claim text.